Needham Reiterates Hold on Amphastar Pharma
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Serge Belanger has reiterated a Hold rating on Amphastar Pharma (NASDAQ:AMPH).

August 08, 2024 | 11:36 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst Serge Belanger has reiterated a Hold rating on Amphastar Pharma (NASDAQ:AMPH).
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100